BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35966325)

  • 1. Diagnosis accuracy of the miR-200 family tumor marker series in ovarian cancer: a systematic review and meta-analysis.
    Liu L; Li P; Wang Q; Dong C; Guo M; Wang R
    Transl Cancer Res; 2022 Jul; 11(7):2283-2290. PubMed ID: 35966325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
    Cui Y; Hong S; Zhu X
    Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
    Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
    Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-21 and microRNA-30c as diagnostic biomarkers for prostate cancer: a meta-analysis.
    Zhou H; Zhu X
    Cancer Manag Res; 2019; 11():2039-2050. PubMed ID: 30881128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
    Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
    Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic value of miR-200 family in breast cancer: A meta-analysis and systematic review.
    Thi Chung Duong T; Nguyen THN; Thi Ngoc Nguyen T; Huynh LH; Ngo HP; Thi Nguyen H
    Cancer Epidemiol; 2022 Apr; 77():102097. PubMed ID: 35030348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-486 as an effective biomarker in cancer diagnosis and prognosis: a systematic review and meta-analysis.
    Jiang M; Li X; Quan X; Yang X; Zheng C; Hao X; Qu R; Zhou B
    Oncotarget; 2018 Mar; 9(17):13948-13958. PubMed ID: 29568407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer.
    Cao Q; Lu K; Dai S; Hu Y; Fan W
    Int J Clin Exp Pathol; 2014; 7(5):2392-401. PubMed ID: 24966949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and meta-analysis of indirect comparison between miRNA and ctDNA in diagnosis of epithelial ovarian cancer.
    Fu X; Liu Y
    Transl Cancer Res; 2021 Dec; 10(12):5372-5382. PubMed ID: 35116384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic value of serum miR-21 in patients with ovarian cancer: a systematic review and meta-analysis.
    Qiu L; Weng G
    J Ovarian Res; 2022 May; 15(1):51. PubMed ID: 35501921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations.
    Teng Y; Su X; Zhang X; Zhang Y; Li C; Niu W; Liu C; Qu K
    Oncotarget; 2016 Dec; 7(49):81621-81633. PubMed ID: 27835595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Cell-Free miR-373, miR-200a, miR-200b and miR-200c in Patients with Epithelial Ovarian Cancer.
    Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
    Adv Exp Med Biol; 2016; 924():3-8. PubMed ID: 27753009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
    Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
    Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Diagnostic Potential of Epigenetically Deregulated MiRNAs in Epithelial Ovarian Cancer.
    Kumar V; Gupta S; Chaurasia A; Sachan M
    Front Oncol; 2021; 11():681872. PubMed ID: 34692473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic and prognostic value of miR-92a in gastric cancer: A systematic review and meta-analysis.
    Guo H; Wang Y; Wang Z; Wang Z; Xue S
    Open Med (Wars); 2021; 16(1):1386-1394. PubMed ID: 34611549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-200 and microRNA-30 family as prognostic molecular signatures in ovarian cancer: A meta-analysis.
    Shi M; Mu Y; Zhang H; Liu M; Wan J; Qin X; Li C
    Medicine (Baltimore); 2018 Aug; 97(32):e11505. PubMed ID: 30095616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic accuracy of TCT + HPV-DNA for cervical cancer: systematic review and meta-analysis.
    Li T; Lai Y; Yuan J
    Ann Transl Med; 2022 Jul; 10(14):761. PubMed ID: 35965790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer.
    Kan CW; Hahn MA; Gard GB; Maidens J; Huh JY; Marsh DJ; Howell VM
    BMC Cancer; 2012 Dec; 12():627. PubMed ID: 23272653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of optical imaging combined with indocyanine green-guided sentinel lymph node biopsy in gastric cancer: a meta-analysis].
    He MF; Jiang ZW; Hao ZW; An J; Zhai J; Shen JK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1196-1204. PubMed ID: 31874538
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic and Prognostic Value of miRNAs in Hepatoblastoma: A Systematic Review With Meta-Analysis.
    Wu B; Zhen K; Guo L; Sun C
    Technol Cancer Res Treat; 2022; 21():15330338221087830. PubMed ID: 35532186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.